John Choi
Neurology · Bethesda, MDNPI 1205862869
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,521 and has fallen 79.9% since, to $306 in 2024.
Across 95 payments — averaging $22.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$488
- Supernus Pharmaceuticals, Inc.$303
- Sanofi$212
- Amgen$143
- CSL Behring$126
- Teva Pharmaceuticals USA, Inc.$93
- plus $727 from 18 others
What the payments were for
- Speaking & faculty fees$171%
- Food & beverage$2,07699%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $488 |
| Supernus Pharmaceuticals, Inc. | 15 | $303 |
| Sanofi | 12 | $212 |
| Amgen | 7 | $143 |
| CSL Behring | 4 | $126 |
| Teva Pharmaceuticals USA, Inc. | 6 | $93 |
| Sunovion Pharmaceuticals Inc. | 6 | $88 |
| Genentech USA, Inc. | 6 | $83 |
| Greenwich Biosciences, Inc. | 5 | $82 |
| Avanir Pharmaceuticals, Inc. | 4 | $65 |
| Adamas Pharmaceuticals, Inc. | 4 | $62 |
| UCB, Inc. | 3 | $49 |
| Biogen | 3 | $44 |
| Grifols USA, LLC | 3 | $43 |
| Lundbeck LLC | 2 | $33 |
| Merz North America, Inc. | 1 | $29 |
| Neurocrine Biosciences, Inc. | 2 | $28 |
| Lilly USA, LLC | 1 | $20 |
| Boston Scientific | 1 | $20 |
| Bayer | 1 | $19 |
| Aquestive Therapeutics, Inc. | 1 | $18 |
| Acorda Therapeutics, Inc | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,093 in reported general payments places this provider in the 55th percentile of 442 neurology providers in Maryland.
Other neurology in Bethesda
- Pavel KleinBethesda$709K
- Jose MasdeuBethesda$56K
- Wilson BryanBethesda$42K
- Daniel BeckerLutherville$1.6M
- Sangjin OhGlen Burnie$1.5M
- Ruwani GunawardaneFulton$479K
- Michael PolydefkisBaltimore$371K
- David CornblathLutherville$345K
- Shiv SaidhaBaltimore$298K
- Santiago Mazuera MesiaBaltimore$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.